News
Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On July 3, Janssen-Cilag, a ...
2d
GlobalData on MSNJ&J eyes prostate cancer label expansion for AkeegaJ&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.
J&J has rights to niraparib in prostate cancer, and views the drug as a successor to Zytiga, once a $2.5 billion-a-year ...
Patients who are on blood thinners are advised to try and avoid nicks of the skin as the medication reduces the ability for ...
When ibuprofen is taken alongside blood thinners it increases a risk of bleeding and so ibuprofen should be avoided. If ...
Croup usually starts with a mild, cold-like illness, characterised by a runny nose, mild fever (around 38.5 °C), and, ...
Johnson & Johnson has announced the submission of an extension of indication application to the European Medicines Agency (EMA) seeking approval of Akeega (niraparib/abiraterone acetate) with ...
A 79-year-old man with recurrent oropharyngeal cancer has developed the first documented case of severe drug-induced interstitial lung disease following photoimmunotherapy with cetuximab-sarotalocan ...
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
Dr Elliot Koranteng Tannor, has cautioned the public against the indiscriminate use of steroids, particularly those found in ...
The main pharmacological interventions for palliation of breathlessness would be opioids, ie, oromorph and benzodiazepines ...
Scott Bessent, US Treasury Secretary, gave a statement noting that the market resilience has shown that the tariffs haven’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results